Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$15.35
0.130.85%
At close: Nov 14, 4:00 PM EST
$15.35
N/A
After Hours: Nov 14, 5:18 PM EST
Comments
Loading...
Aurinia Pharmaceuticals (AUPH) Stock Price, Quote, News & History
AUPHNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Aurinia Pharmaceuticals (AUPH) stock?
You can purchase shares of Aurinia Pharmaceuticals (NASDAQ:AUPH) through any online brokerage.
Who are Aurinia Pharmaceuticals (AUPH) competitors?
Other companies in Aurinia Pharmaceuticals’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), Sarepta Therapeutics (NASDAQ:SRPT), Mesoblast (NASDAQ:MESO) and Agios Pharmaceuticals (NASDAQ:AGIO).
What is the forecast, or price target, for Aurinia Pharmaceuticals (AUPH) stock?
Aurinia Pharmaceuticals has a consensus price target of $15.20.
What is the current price for Aurinia Pharmaceuticals (AUPH)?
The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $15.35 last updated November 14, 2025 at 5:18 PM EST.
Does Aurinia Pharmaceuticals (AUPH) pay a dividend?
There are no upcoming dividends for Aurinia Pharmaceuticals.
When is Aurinia Pharmaceuticals (NASDAQ:AUPH) reporting earnings?
Aurinia Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, November 4, 2025.
Is Aurinia Pharmaceuticals (AUPH) going to split?
There is no upcoming split for Aurinia Pharmaceuticals.
What sector and industry does Aurinia Pharmaceuticals (AUPH) operate in?
Aurinia Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
